Ledger.Open graph →
SEC Form D · filed June 15, 2016

PIERIS PHARMACEUTICALS, INC

Offering
$16.5M
Sold
$16.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Steven S. Prelack · Boston, MADirectorDarlene S. Deptula-Hicks · Boston, MAExecDarlene S. Deptula-Hicks · Boston, MAExecStephen S. Yoder · Boston, MAExec · DirectorChau S. Khuong · Boston, MADirectorSteven S. Prelack · Boston, MADirectorJean-Pierre S. Bizzari · Boston, MADirectorMichael S. Richman · Boston, MADirectorRob Keve · Hoboken, NJDirectorMartin Matern · Luxembourg, LuxembourgDirectorRaymond Lane · San Francisco, CAExec · DirectorMichael Bryzek · Hoboken, NJExec · DirectorJean-Pierre S. Bizzari · Boston, MADirectorChau S. Khuong · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗